ANG Lifesciences India Limited (BOM:540694)
24.03
-1.12 (-4.45%)
At close: Jan 19, 2026
ANG Lifesciences India Market Cap
ANG Lifesciences India has a market cap or net worth of 324.11 million as of January 23, 2026. Its market cap has decreased by -47.66% in one year.
Market Cap
324.11M
Enterprise Value
1.19B
Revenue
922.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.03
Market Cap Chart
Since September 8, 2017, ANG Lifesciences India's market cap has decreased from 497.60M to 324.11M, a decrease of -34.87%. That is a compound annual growth rate of -4.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 315.23M | -18.31% |
| Dec 31, 2025 | 385.87M | -33.77% |
| Dec 31, 2024 | 582.66M | -35.72% |
| Dec 29, 2023 | 906.38M | -42.23% |
| Dec 30, 2022 | 1.57B | -67.78% |
| Dec 31, 2021 | 4.87B | 1,136.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Welcure Drugs and Pharmaceuticals | 457.30M |
| Walpar Nutritions | 449.33M |
| Murae Organisor | 446.15M |
| Vilin Bio Med | 366.19M |
| Sandu Pharmaceuticals | 357.94M |
| Panjon | 355.13M |
| Gujarat Terce Laboratories | 353.18M |
| JFL Life Sciences | 349.75M |